# Eli Lilly and Company (LLY) — Q4-2012 Earnings Results

**Report date:** 2013-01-29 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2012

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.85 | N/A | +8.42% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautious optimism about the company's performance. They emphasized their commitment to innovation despite market challenges.

**Key quotes:**

> Management highlighted the positive impact of recent product launches.

> They acknowledged ongoing challenges in the market but expressed confidence in their pipeline.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Eli Lilly's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, but the company's focus on product innovation suggests potential growth opportunities ahead.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2012_